APOL1 nephropathy: from gene to mechanisms of kidney injury (Q38308481)

2 September 2017

1 reference

title

APOL1 nephropathy: from gene to mechanisms of kidney injury (English)

1 reference

2 September 2017

1 reference

2

Walter G Wasser

1 reference

2 September 2017

4

Karl Skorecki

1 reference

2 September 2017

Etty Kruzel-Davila

1

1 reference

2 September 2017

Sharon Aviram

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

5 January 2015

1 reference

Nephrology Dialysis Transplantation

2 September 2017

published in

1 reference

2 September 2017

volume

31

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

349-358

1 reference

Lifetime incidence of CKD stages 3-5 in the United States

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Segregation, income disparities, and survival in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The familial risk of end-stage renal disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Apolipoprotein L-I is the trypanosome lytic factor of human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Evolution of the primate trypanolytic factor APOL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Bringing genome-wide association findings into clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Population genetics of chronic kidney disease: the evolving story of APOL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Absence of HIV-associated nephropathy in Ethiopians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Increased burden of cardiovascular disease in carriers of APOL1 genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Population-based risk assessment of APOL1 on renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Genetic variation in APOL1 associates with younger age at hemodialysis initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Plasma apolipoprotein L1 levels do not correlate with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 variants associate with increased risk of CKD among African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 risk variants, race, and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 and progression of nondiabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

End-stage renal disease in African Americans with lupus nephritis is associated with APOL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Nutrient sensing, autophagy, and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

21 January 2018

APOL1 and kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The function of apolipoproteins L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

APOL1 localization in normal kidney and nondiabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The APOL1 gene and allograft survival after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

African American living-kidney donors should be screened for APOL1 risk alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Gene-gene interactions in APOL1-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

The innate immune factor apolipoprotein L1 restricts HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU391

21 January 2018

Identifiers

DOI

10.1093/NDT/GFU391

1 reference

2 September 2017

1 reference